Clinical Trial Update: Efficacy and Safety of Single Dose of 5 mg Zoledronic Acid in Chinese Patients With Paget's Disease of Bone (PDB) [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluates the efficacy and safety of a single 5 mg dose of zoledronic acid in Chinese patients with Paget's Disease of Bone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paget Disease of Bone

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Paget's Disease of Bone | Phase 4 | Status: COMPLETED